Human chimeric antigen receptor macrophages for cancer immunotherapy.

MLA

Klichinsky, Michael, et al. “Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy.” Nature Biotechnology, vol. 38, no. 8, Aug. 2020, pp. 947–53. EBSCOhost, https://doi.org/10.1038/s41587-020-0462-y.

APA

Klichinsky, M., Ruella, M., Shestova, O., Lu, X. M., Best, A., Zeeman, M., Schmierer, M., Gabrusiewicz, K., Anderson, N. R., Petty, N. E., Cummins, K. D., Shen, F., Shan, X., Veliz, K., Blouch, K., Yashiro-Ohtani, Y., Kenderian, S. S., Kim, M. Y., O’Connor, R. S., … Gill, S. (2020). Human chimeric antigen receptor macrophages for cancer immunotherapy. Nature Biotechnology, 38(8), 947–953. https://doi.org/10.1038/s41587-020-0462-y

Chicago

Klichinsky, Michael, Marco Ruella, Olga Shestova, Xueqing Maggie Lu, Andrew Best, Martha Zeeman, Maggie Schmierer, et al. 2020. “Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy.” Nature Biotechnology 38 (8): 947–53. doi:10.1038/s41587-020-0462-y.